TABLE 1.
Studies on intervention of UPR in cerebral ischemia.
| UPR | Intervention | Related protein changes | Ischemia model | Effects | References |
| PERK pathway | Hes1 knockdown | Activating the PERK/eIF2α/ATF4/CHOP signaling pathway | tMCAO | Knockdown of Hes1 increased cerebral infarction, worsened nervous system prognosis, and promoted ER stress-induced apoptosis. | Li L. et al., 2020 |
| PERK-cKO by cross-breeding Camk2a-CreERT2 with Perkf/f mice | Decreasing the expression of p-eIF2α and p-perk | tMCAO/BCAO | Decreased neurological scores and increased infarct volume in PERK-cKO mice. | Wang et al., 2020 | |
| Overexpression of ATF4 induced by adeno-associated virus | Increasing the expression of ATF4 | MCAO | Overexpressed ATF4 reduced cerebral infarction volume, lowered neurological score and improves HE and Nissl staining. | He et al., 2019 | |
| Giving mice a subcutaneous injection of G-CSF (50 μg/kg) for 4 days | Decreasing the expression of ATF4, CHOP, capase-12 | BCAO | G-CSF can’t only reduce acute neuronal degeneration, but also increase long-term plasticity after cerebral ischemia, and maintain cell homeostasis by reducing pro-apoptotic proteins and increasing anti-apoptotic proteins. | Modi et al., 2020 | |
| ATF4 silencing | Decreasing the expression of PARK2 and PARK2-dependent mitophagy | tMCAO | The silencing of ATF4 gave rise to the disappearance of the neuroprotective effects where the volume of cerebral infarction decreases and the absorption rate of glucose in ischemic tissue increases induced by tunicamycin and thapsigargin. | Zhang X. et al., 2014 | |
| Continuous injection of chrysophanol (0.1 mg/kg) for 14 days | Decreasing the expression of CHOP, GRP78, p-eIF2α, caspase-12 and increasing the expression of anti-inflammatory factor IκB-α | MCAO | CHR exerted anti-inflammatory effects by inhibiting ER stress response after I/R while reducing neuronal apoptosis. | Zhao et al., 2018 | |
| Hypothermia (31°C) | Decreasing the expression of CHOP and Ero1-α | MCAO | Hypothermia inhibited apoptosis of stroke cells induced by endoplasmic reticulum stress. | Poone et al., 2015 | |
| Salubrinal | Increasing the expression of p-eIF2α and GADD34 | MCAO | Salubrinal played a neuroprotective effect by reducing CA1 cell death and blood-brain barrier damage. | Nakka et al., 2010; Anuncibay-Soto et al., 2016 | |
| IRE1 pathway | Overexpression of XBP1s induced by adenovirus transduction | Increasing the expression of XBP1s | ODG/R of primary rat hippocampal neurons | Overexpression of XBP1s suppressed cell death induced by OGD/R stress. | Ibuki et al., 2012 |
| Give Icariin to microglia and hippocampal neurons 1 h before OGD | Decreasing the ratio of p-IRE1α/IRE1α, the expression of XBP1s and IL-β, IL-6, TNF-α | ODG/R of primary microglia and cortical neurons | Increased viability of primary cortical neuron cells treated with Icariin. | Shaulian and Karin, 2002 | |
| Using melatonin (5 mg/kg) at the beginning of reperfusion | Suppressing the PERK/eIF2α/ATF4/CHOP signaling pathway | MCAO | The infarct volume and individual skin lesion size of melatonin-treated mices were significantly reduced, and the number of surviving neurons increased. | Lin et al., 2018 | |
| Melatonin pretreatment before cerebral ischemia | Decreasing the expression of p-perk and p-IRE1 | tMCAO | Melatonin pretreatment markly relieved cerebral infarction, cerebral edema, neuronal apoptosis and nervous system defects. | Feng et al., 2017 | |
| ATF6 pathway | ATF6 pharmacological activation by a compound called 147 | Increasing the expression of GRP78 and catalase | MCAO | The pharmacological activation of ATF6 stabilized the reprogramming protein, reduces damage and preserves brain function. | Blackwood et al., 2019 |
| Taurine | Downregulating the ratio of cleaved ATF6, full-length ATF6, p-IRE1, caspase-12, CHOP and Bax | MCAO ODG/R of primary cortical neurons | Taurine not only caused neuroprotection through the ATF6 and IRE1 pathways, but also reduces apoptosis and cerebral infarction volume in these model. | Gharibani et al., 2013 |